07:00 Fri 22 Jan 2021
Directa Plus PLC - Addition to Decontamination and Recovery Contract

Directa Plus plc
("Directa Plus" or the "Company")
Addition to Oil Decontamination and Recovery Contract
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that it has had its contract (the "Contract") with OMV Petrom extended and increased. The Contract, initially awarded in
The initial value of the contract was
The Contract relates to oil recovery from existing high-volume emulsions stored in the OMV Petrom Tank Farms in
Directa Plus's patented Grafysorber® technology is a commercially-available graphene-based solution for treating water sludges and emulsions containing hydrocarbons and is at least five times more effective than current technologies - adsorbing more than 100 times its own weight of oil-based pollutants. In addition, Grafysorber® is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.
Commenting,
This announcement has been approved by
For further information please visit www.directa-plus.com or contact:
Directa Plus plc | +39 02 36714458 |
|
|
|
|
|
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) | +44 131 220 6939 |
|
|
|
|
N+1 Singer (Joint Broker) | +44 20 7496 3069 |
|
|
|
|
Tavistock (Financial PR and IR) | +44 20 7920 3150 |
|
|
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.
-ends-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
